Fermenta Biotech Ratios

Fermenta Biotech Ltd Ratios

The Fermenta Biotech Ltd Ratios page provides a complete fundamental analysis of Fermenta Biotech Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Fermenta Biotech Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Fermenta Biotech Ltd (NSE: , BSE: 506414) is currently trading at ₹336.60, with a market capitalization of ₹9.99B. As a major player in the Health technology sector and Biotechnology industry, Fermenta Biotech Ltd remains a key stock for fundamental analysis using Fermenta Biotech Ltd Ratios.

Fermenta Biotech Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Fermenta Biotech Ltd P/E ratio currently stands at 10.38, making it one of the most tracked metrics in Fermenta Biotech Ltd Ratios.

Historically, the Fermenta Biotech Ltd P/E ratio has shown strong fluctuations:

• 2024: 10.38
• 2023: 0
• 2022: 0
• 2021: 38.41
• 2020: 15.87

The rising Fermenta Biotech Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Fermenta Biotech Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 2.20.

Historical P/B trend:

• 2024: 2.20
• 2023: 1.51
• 2022: 0.98
• 2021: 1.59

Fermenta Biotech Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Fermenta Biotech Ltd P/S ratio currently stands at 1.70, an important part of Fermenta Biotech Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 1.70
• 2023: 1.31
• 2022: 0.88
• 2021: 1.49

The rising Fermenta Biotech Ltd P/S ratio indicates improved revenue valuation by investors.

Fermenta Biotech Ltd Price to Cash Flow Ratio (P/CF)

The Fermenta Biotech Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 24.57.

Historical Fermenta Biotech Ltd Price to Cash Flow Ratio:

• 2024: 24.57
• 2023: 4.75
• 2022: 3.14
• 2021: 20.37
• 2020: 14.48

The rising Fermenta Biotech Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Fermenta Biotech Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Fermenta Biotech Ltd EV currently stands at ₹8.37B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 8.37B
• 2023: 5.12B
• 2022: 4.64B
• 2021: 7.98B

Fermenta Biotech Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Fermenta Biotech Ltd EV/EBITDA ratio is currently 7.38, a key metric in Fermenta Biotech Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 7.38
• 2023: 17.99
• 2022: 21.95
• 2021: 12.79

Stable Fermenta Biotech Ltd EV/EBITDA indicates balanced valuation.

Fermenta Biotech Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Fermenta Biotech Ltd D/E ratio is currently 0.32, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.32
• 2023: 0.48
• 2022: 0.70
• 2021: 0.64

Fermenta Biotech Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Fermenta Biotech Ltd ROE currently stands at 23.59%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 23.59
• 2023: -7.64
• 2022: -14.86
• 2021: 4.22

Fermenta Biotech Ltd demonstrates strong profitability and efficient capital utilization.

Fermenta Biotech Ltd Ratios Analysis Summary

The Fermenta Biotech Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Fermenta Biotech Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Fermenta Biotech Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.